Advertisement
Research Article| Volume 7, ISSUE 3, P669-686, September 1987

Download started.

Ok

Cyclosporine Controversies

  • Benjamin Gerson
    Correspondence
    New England Deaconess Hospital, Department of Pathology, 185 Pilgrim Road, Boston, Massachusetts 02215
    Affiliations
    Associate Professor, Department of Pathology, Harvard Medical School, and Director, Clinical Chemistry and Diagnostic Immunology, New England Deaconess Hospital, Boston, Massachusetts
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30738-8
Cyclosporine Controversies
Previous ArticleDetection of Androgenic Anabolic Steroids in Urine
Next ArticleMonitoring of Anti-Inflammatory Drugs
      This paper is only available as a PDF. To read, Please Download here.
      Cyclosporine is a potent immunosuppressant with low myelotoxicity. It is approved for use to prevent rejection of kidney, liver, and heart transplants, and is being investigated for possible use for suppression of graft-versus-host disease in patients who have received bone marrow transplants. Although cyclosporine is generally thought of as an immunosuppressive agent for use in conjunction with transplantation, there are investigations underway that could result in wider applications.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Andrus L.
        • Lafferty K.J.
        Inhibition of T cell activation by cyclosporin A.
        Scand J Immunol. 1982; 15: 449-458
        • Annesley T.M.
        • Giacherio D.A.
        • Feldkamp C.S.
        The concentration related distribution of cyclosporine in blood.
        J Clin Immunoassay. 1986; 9: 53-56
        • Berg K.J.
        • Forre O.
        • Bjerkhoel F.
        • et al.
        Side effects of cyclosporin A treatment in patients with rheumatoid arthritis.
        Kidney Int. 1986; 29: 1180-1189
        • Beveridge T.
        • Gratwohl A.
        • Michot F.
        • et al.
        Cyclosporin A. Pharmacokinetics after a single dose in man and serum levels after multiple dosing in recipients of allogenic bonemarrow grafts.
        Curr Ther Res. 1981; 30: 280-293
        • Borei J.F.
        Cyclosporine: Historical perspectives.
        Transplant Proc. 1983; 15: 2220
        • Borei J.F.
        • Lafferty K.J.
        Cylosporine: Speculation about its mechanism of action.
        Transplant Proc. 1983; 15: 1881
        • Bourbigot B.
        Nicardipine increases cyclosporine blood levels.
        Lancet. 1986; i: 1447
        • Bowers L.D.
        • Canafax D.M.
        Cyclosporine: Experience with therapeutic drug monitoring.
        Ther Drug Monit. 1984; 6: 142-147
        • Bunjes D.
        • Hardt C.
        • Rollinghoff M.
        • Wagner H.
        Cyclosporin A mediates immunosuppression of primary cytotoxic T-cell responses by impairing the release of interleukin 1 and interleukin 2.
        Eur J Immunol. 1981; 11: 657-661
        • Caine R.Y.
        • White D.J.G.
        • Thiru S.
        • et al.
        Cyclosporin A in clinical organ grafting.
        Transplant Proc. 1981; 13: 356
        • Cannafax D.M.
        • Ascher N.L.
        Cyclosporine immunosuppression.
        Clin Pharm. 1983; 2: 515-524
        • Carruthers S.G.
        • Freeman D.J.
        • Koegler J.C.
        • et al.
        Simplified liquid chromatographic analysis for cyclosporin A, and comparison with radioimmunoassay.
        Clin Chem. 1983; 29: 180-183
        • Cefalua W.T.
        • Pardridge W.M.
        Restrictive transport of a lipid-soluble peptide (cyclosporine) through the blood-brain barrier.
        J Neurochem. 1985; 45: 1954-1956

      14. Cohen DJ: Cyclosporine: Clinical applications and monitoring methods. Lab Management Jan 1985, pp. 29-34

        • Conley S.B.
        • Flechner S.M.
        • Rose G.
        • et al.
        Use of cyclosporine in pediatric renal recipients.
        J Pediatr. 1985; 106: 45-49
      16. Cyclosporin in autoimmune disease (editorial).
        Lancet. 1985; i: 909-911
        • Donatsch P.
        • Abisch E.
        • Hornberger M.
        • et al.
        A radioimmunoassay to measure cyclosporin A in plasma and serum samples.
        J Immunol. 1981; 2: 19-32
        • Grevel J.
        Absorption of cyclosporin A after oral dosing.
        Transplant Proc. 1986; 28: 9-15
        • Grino J.M.
        Influence of diltiazem on cyclosporine clearance.
        Lancet. 1986; i: 1387
        • Gumbelton M.
        • Brown J.E.
        • Hawksworth G.
        • Whiting P.H.
        The possible relationship between hepatic drug metabolism and ketoconazole enhancement of cyclosporine nephrotoxicity.
        Transplantation. 1985; 40: 454-455
        • Gurecki J.
        • Warty V.
        • Sanghvi A.
        The transport of cyclosporine in association with plasma lipoproteins in heart and liver transplant patients.
        Transplant Proc. 1985; 17: 1997-2002
        • Harwood C.H.
        • Cook C.V.
        Cyclosporine in transplantation.
        Heart Lung. 1985; 14: 529-540
        • Handschumacher R.E.
        • Harding M.W.
        • Rice J.
        • Drugge R.J.
        Cyclophilin: A specific cytosolic binding protein for cyclosporin A.
        Science. 1984; 226: 544-547
        • Hows J.M.
        • Smith J.M.
        In vitro stability of cyclosporin A.
        Clin Chem. 1983; 29: 720-721
        • Iwatsuki S.
        • Esquivel C.O.
        • Klintmalm G.B.G.
        • et al.
        Nephrotoxicity of cyclosporine in liver transplantation.
        Transplant Proc. 1985; 17: 191-195
        • Joss D.V.
        • Barrett A.J.
        • Kendra J.R.
        • et al.
        Hypertension and convulsions in children receiving cyclosporin A.
        Lancet. 1982; i: 906
        • Kabra P.M.
        • Wall J.H.
        • Blanckaert N.
        Solid phase extraction and liquid chromatography of improved assay of cyclosporine in whole blood or plasma.
        Clin Chem. 1985; 31: 1717-1720
        • Kahan B.
        Individualization of cyclosporine therapy using pharmacokinetics and pharmacodynamic parameters.
        Transplantation. 1985; 40: 457-476
        • Kahan B.D.
        Cyclosporine: The agent and its actions.
        in: Kahan B.D. Cyclospor ine—Diagnosis and Management of Associated Renal Injury. Grune and Stratton, Orlando1985: 5-18
        • Kahan B.D.
        • Ried M.
        • Newburger J.
        Pharmacokinetics of cyclosporine in human renal transplantation.
        Transplant Proc. 1983; 15: 446-453
        • Kalman V.
        • Klimpel G.R.
        Cyclosporin A inhibits the production of gamma interferon (IFN-gamma) but does not inhibit production of virus induced IFN alpha/beta.
        Cell Immunol. 1983; 78: 122-129
        • Kennedy M.S.
        Clinical problems with the use of cyclosporine in marrow transplant.
        J Cell. 1983; Biochem (Abstr No. 0139): 58
        • Keown P.A.
        • Laupacis A.
        • Carruthers G.
        • Staweck M.
        Interaction between phenytoin and cyclosporine following organ transplantation.
        Transplantation. 1984; 38: 304-306
        • Keown P.A.
        • Stiller C.R.
        • Laupacis A.L.
        • et al.
        The effects and side effects of cyclosporine: Relationship to drug pharmacokinetics.
        Transplant Proc. 1982; 14: 659-661
        • Keown P.A.
        • Stiller C.R.
        • Sinclair N.R.
        • et al.
        The clinical relevance of cyclosporine blood levels as measured by radioimmunoassay.
        in: Kahan B.D. Cyclosporine. Volume I. Grune and Stratton, Orlando1984: 222-225
        • Kohan D.E.
        Possible interaction between cyclosporine and erythromycin.
        N Engl J Med. 1986; 314: 448
        • Kolbeck P.C.
        • Scheinman J.I.
        • Sanfilippo F.
        Acute cellular rejection and cyclosporine nephrotoxicity monitored by biopsy in a renal allograft rejection.
        Arch Pathol Lab Med. 1986; 110: 389-393
        • Lemaire M.
        • Tillement J.P.
        Role of lipoproteins and erythrocytes in the in vivo binding and distribution of cyclosporin A in blood.
        J Pharm Pharmacol. 1983; 34: 715-718
        • Lokiec F.
        • Devergie A.
        • Poirier O.
        • Gluckman E.
        Pharmacologic monitoring in the clinical use of cyclosporine.
        in: Kahan B.D. Cyclosporine. Volume I. Grune and Stratton, Orlando1984: 226-229
        • Mahoney W.C.
        • Orf J.W.
        Derivation of cyclosporin compatible with antibody-based assays: I. The generation of 125I-labeled cyclosporin.
        Clin Chem. 1985; 31: 459-462
        • Manger B.
        • Hardy K.J.
        • Weiss A.
        • Stobo J.D.
        Differential effect of cyclosporin A on activation signaling in human T cell lines.
        J Clin Invest. 1986; 77: 1501-1506
        • Marder P.
        • Schmidtke J.R.
        Cyclosporin A inhibits helper/inducer surface antigen expression on activated human lymphocytes.
        Int J Immunopharmacol. 1985; 2: 165-175
        • McMiller M.A.
        • Trsi R.J.
        • Baumgarten W.B.
        • et al.
        Potentiation of cyclosporine by verapamil in vitro.
        Transplantation. 1985; 40: 444-446
        • Merion R.M.
        • White D.J.G.
        • Thiru S.
        • et al.
        Cyclosporine: Five years’ experience in cadaveric renal transplantation.
        N Engl J Med. 1984; 310: 148-154
        • Moyer T.P.
        • Johnson P.
        • Faynor S.M.
        • Sterioff S.
        Cyclosporine: A review of drug monitoring problems and presentation of a simple, accurate liquid chromatographic procedure that solves these problems.
        Clin Biochem. 1986; 19: 83-89
        • Myers B.D.
        • Ross J.
        • Newton L.
        • et al.
        Cyclosporine-associated chronic nephropathy.
        N Engl J Med. 1984; 311: 699-705
        • Niederberger W.
        • Lemaire M.
        • Nussbaumer K.
        • et al.
        Distribution of cyclosporine in blood components and tissues.
        Transplant Proc. 1983; 15: 2419-2421
        • Niederberger W.
        • Schaub P.
        • Beveridge T.
        High performance liquid chromatographic determination of cyclosporin A in human plasma and urine.
        J Chromatogr. 1980; 182: 454-458
        • Palestine A.G.
        • Austin H.A.
        • Balow F.E.
        • et al.
        Renal histopathologic alterations in patients treated with cyclosporine uveitis.
        N Engl J Med. 1986; 314: 1293-1298
        • Parker D.
        • Drossier K.
        • Turk T.L.
        Kinetics of the effect of a single dose of cyclosporin A on antibody and cell mediated immune responses in the guinea pig.
        Int J Immunopharmacol. 1984; 6: 67-74
        • Powell-Jackson P.R.
        • Carmichael F.J.L.
        • Caine R.Y.
        • Williams R.
        Adult respiratory distress syndrome and convulsions associated with administration of cyclosporine in liver transplant recipients.
        Transplantation. 1984; 38: 341-343
        • Pochet J.M.
        Cyclosporine-diltiazem interaction.
        Lancet. 1986; i: 979
        • Ptachinski R.
        • Venkataramanan R.
        • Burckart G.J.
        Clinical pharmacokinetics of cyclosporin.
        Clin Pharmacokinet. 1986; 11: 107-132
        • Randall G.
        • Jacobs P.
        Cyclosporine-A radioimmunoassay: A modified method for whole blood determination.
        Exp Hematol. 1985; 13: 879
        • Robinson W.T.
        • Schran H.F.
        • Barry E.P.
        Methods to measure cyclosporine levels—high pressure liquid chromatography, radioimmunoassay correlation.
        Transplant Proc. 1983; 4: 2403-2408
        • Rosano T.G.
        Effect of hematocrit on cyclosporine (cyclosporin A) in whole blood and plasma of renal-transplant patients.
        Clin Chem. 1985; 31: 410-412
        • Rowland M.
        Critique of cyclosporine pharmacokinetic measurements.
        Transplant Proc. 1986; 6: 257-262
        • Sanghvi A.
        Impact of organ transplant program on the clinical chemistry laboratory at the University of Pittsburgh.
        Arch Pathol Lab Med. 1986; 110: 95-97
        • Sawchuk R.J.
        • Cartrer L.L.
        Liquid-chromatographic determination of cyclosporin A in blood and plasma.
        Clin Chem. 1981; 27: 1368-1371
        • Schran H.F.
        • Abisch E.
        Monitoring of cyclosporine: A status report.
        Ther Drug Monit. 1984; 6: 371-375
        • Shepard J.H.
        Cyclosporine-ketoconazole: A potentially dangerous drug-drug interaction.
        Clin Pharm. 1986; 5: 648
        • Shidani B.
        • Colle J.H.
        • Motta I.
        • Truffa-Bachi P.
        Effects of cyclosporin A on induction and activation of B memory cells by thymus independent antigens in mice.
        Eur J Immunol. 1983; 5: 359-363
        • Smith J.
        • Hows J.
        • Gordon-Smith E.D.
        In vitro stability and storage of cyclosporine in human serum and plasma.
        Transplant Proc. 1983; 15: 2422-2425
        • Starzl T.E.
        • Nalesnik M.A.
        • Porter K.A.
        • et al.
        Reversibility of lymphoma and lymphoproliferative lesions developing under cyclosporin-steroid therapy.
        Lancet. 1984; i: 583-587
        • Stiller C.R.
        • Dupre J.
        • Gent M.
        • et al.
        Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset.
        Science. 1984; 223: 1763
        • Thompson C.B.
        • Sullivan K.
        • June C.H.
        • Thomas E.D.
        Association between cyclosporin neurotoxicity and hypomagnesemia.
        Lancet. 1984; 2: 1116-1120
        • Tosato G.
        • Pike S.E.
        • Koski I.R.
        • Blaese R.M.
        Selective inhibition of immunoregulatory cell function by cyclosporin A.
        J Immunol. 1982; 128: 1986-1991
        • Vine W.
        • Flye M.W.
        • Jatlow P.
        Relationships of cyclosporine concentrations in serum, whole blood, and bile after renal and hepatic transplantation.
        Clin Chem. 1986; 32: 1828-1831
        • Venkataramanan R.
        • Ptachinski R.
        • Burckart G.J.
        • et al.
        The clearance of cyclosporine by hemodialysis.
        J Clin Pharmacol. 1984; 24: 528-531
        • Wenk M.
        • Follath F.
        • Abisch E.
        Temperature dependency of apparent cyclosporin A concentrations in plasma.
        Clin Chem. 1983; 29: 1865
        • White D.J.G.
        • McNaughton D.
        • Caine R.Y.
        Is the monitoring of cyclosporin-A serum levels of clinical value?.
        Transplant Proc. 1983; 15: 454-456
        • Whiting P.H.
        • Simpson J.G.
        The enhancement of cyclosporin A-induced nephrotoxicity by gentamicin.
        Biochem Pharm. 1983; 32: 2025-2028
        • Wideman C.A.
        Pharmacokinetic monitoring of cyclosporine.
        Transplant Proc. 1983; 4: 3168-3175
        • Wood A.J.
        • Maurer G.
        • Niederbenger W.
        • Beveridge T.
        Cyclosporine: Pharmacokinetics, metabolism, and drug interactions.
        Transplant Proc. 1983; 15: 2409-2412
        • Yee G.C.
        • Gmur D.J.
        • Kennedy M.S.
        Liquid chromatographic determination of cyclosporine in serum with use of a rapid extraction procedure.
        Clin Chem. 1982; 28: 2269-2271
        • Yee G.C.
        • Kennedy M.
        • Storb R.
        • Thomas E.D.
        Pharmacokinetics of intravenous cyclosporine in bone marrow transplant patients.
        Transplantation. 1984; 38: 511-513
        • Yee G.C.
        • Kennedy M.S.
        • Storb R.
        • Thomas E.D.
        Effect of hepatic dysfunction on oral cyclosporine pharmacokinetics in marrow transplant patients.
        Blood. 1984; 64: 1277-1279

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30738-8

      Copyright

      © 1987 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX